Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra)

The combination of sodium hydrogen carbonate, magnesium chloride, sodium chloride and calcium chloride delivers essential ions directly into the bloodstream. Bicarbonate buffers excess acid, while the cations restore extracellular electrolyte concentrations, supporting normal cellular function during dialysis.

The prescribed dose of Multibic is determined by the treating physician based on the patient’s individual dialysis prescription, electrolyte status and fluid balance. Dosage is tailored to each clinical situation and is not standardized.

Safety data for Multibic in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Multibic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Multibic offers a balanced mix of sodium, chloride, calcium, magnesium and bicarbonate, making it suitable for comprehensive electrolyte and acid‑base management during dialysis. Compared with single‑ion solutions, it reduces the need for multiple infusions and simplifies fluid management, though choice of product depends on specific patient needs and institutional protocols.

Multibic should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations to maintain stability and sterility.

Multibic is administered intravenously, typically as part of the dialysis circuit or via a controlled infusion pump. The rate and volume are adjusted by the dialysis team according to the patient’s prescribed treatment plan and real‑time electrolyte monitoring.

Serious risks include severe hypernatremia, hypercalcemia, hypermagnesemia, metabolic alkalosis, cardiac arrhythmias and anaphylactic reactions. Continuous monitoring of electrolyte levels and patient vitals during infusion helps mitigate these risks.

Multibic is contraindicated in patients with known hypersensitivity to any of its components, as well as those with severe hypercalcemia, hypermagnesemia or uncontrolled metabolic alkalosis. Clinicians should also exercise caution in patients with fluid overload or severe heart failure.